Shanghai Techwell Biopharmaceutical

Shanghai Techwell Biopharmaceutical is a specialized biopharmaceutical company focused on the development and large-scale production of fermentation-based APIs and synthetic peptides. As a subsidiary of Fosun Pharma, the company leverages its expertise in microbial fermentation and sophisticated chiral synthesis to produce high-value medicines for endocrinology, oncology, and infectious diseases. Their portfolio includes key products such as Liraglutide, Semaglutide, and various echinocandin antifungals. Techwell maintains high-standard GMP facilities and serves a global market, providing both proprietary products and contract manufacturing services.